- Pharmaceutical scientists working on neuroscience drug discovery
- Clinical researchers working on neuroscience drug discovery
- Academic researches on neuroscience drug discovery
- Ex vivo slice model of inflammasome activation
- How this can be used to characterize NLRP3 inhibitor drug candidates
- Pathways in neuroinflammation
15 minute webinar: Why you need ex vivo inflammasome slice assay for neuroinflammation discovery
October 25, 2022 10:00 - 10:30 ET - Virtual
About The Event
You can learn a lot in 15 minutes. Join us for a short webinar to learn how our scientists can support your neuroscience drug discovery projects. Ex vivo inflammasome slice assay for neuroinflammation discovery If you are working in neuroinflammation and neurodegeneration you will know about the importance of understanding the complex signaling between different cell types in a native system. Sometimes studying the biology of your drug candidate in single cell systems just isn’t enough. Specializing in neuroinflammation, neurodegeneration and remyelination, CLS can provide you with a range of ex vivo slice models. Slice cultures maintain all the relevant cells, structure and organization of the brain in thick sections of tissue that have been cultured ex vivo. The system can be tailored to region- and circuit-specific requirements. In this short webinar, Dr Elise Malavasi, principal scientist at CLS, will: • Introduce the NLRP3 Inflammasome Pathway and its involvement in neurodegenerative diseases • Show how NLRP3 inflammasome activation and inhibition can be modelled ex vivo using brain slices • Explain how ex vivo slice models are applied to the characterization of drug candidates targeting the inflammasome system Following Dr Malavasi’s presentation, you will get the chance to put your questions to our her in a live question and answer session.
More Information
Who should attend?
What will you learn?